mRNA vaccine manufacturer building local production capacity in Argentina
SINERGIUM Biotech is a 13-year-old Argentine biotech manufacturer scaling mRNA vaccine production through technology transfer programs. The stack is heavily weighted toward manufacturing execution (SAP, Jira, AutoCAD, SolidWorks, Microsoft Project) and operational planning tools — a footprint typical of a company building a new GMP facility rather than a software-first biotech. Active projects center on mRNA technology transfer and lean manufacturing implementation, while hiring spans engineering, manufacturing, and research roles at mid-level seniority, signaling both facility ramp-up and process maturity work.
SINERGIUM Biotech manufactures seasonal and pandemic influenza vaccines, with a strategic focus on expanding into mRNA vaccine production and local manufacturing capacity. The company is headquartered in Garin, Buenos Aires, and employs 201–500 people across engineering, manufacturing, operations, research, finance, and logistics functions. Core business challenges center on reducing import dependency, building export capability, and establishing Argentina as a regional vaccine production hub — a mission reflected in active technology transfer programs and thermo-mechanical development projects.
Manufacturing and planning tools dominate: SAP (with Fiori UI and BTP platform), AutoCAD, SolidWorks, Microsoft Project, Jira, Asana, Trello, and Qlik Sense for analytics. Stack reflects a production-focused org building GMP-compliant manufacturing capacity.
Core projects include mRNA vaccine production, technology transfer programs, thermo-mechanical development, lean management implementation, and reducing operational losses. Strategic focus is replacing imports and building export potential for local vaccine manufacturing.
Other companies in the same industry, closest in size